Cargando…
The Effectiveness of “Two-Week” Referrals for Suspected Bone and Soft Tissue Sarcoma
The two-week “wait” target introduced in 2000 requires that patients with suspected cancer referred by general practitioners should be seen within two weeks. We reviewed patients who had been referred under this standard to the North of England Bone and Soft Tissue Tumour Service, to determine if th...
Autores principales: | Malik, A., Wigney, L., Murray, S., Gerrand, C. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235930/ https://www.ncbi.nlm.nih.gov/pubmed/18288262 http://dx.doi.org/10.1155/2007/23870 |
Ejemplares similares
-
Delays in Referral of Soft Tissue Sarcomas
por: Johnson, G. D., et al.
Publicado: (2008) -
Ecteinascidin-743: Evidence of Activity in Advanced,
Pretreated Soft Tissue and Bone Sarcoma Patients
por: Huygh, G., et al.
Publicado: (2006) -
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012) -
UK guidelines for the management of soft tissue sarcomas
por: Dangoor, Adam, et al.
Publicado: (2016) -
Knowledge or noise? Making sense of General Practitioners’ and Consultant use of 2-week-wait referrals for suspected cancer
por: Donnelly, Conan, et al.
Publicado: (2017)